Holen Sie sich die Stockscreener-App
7.51
7.40%
-0.60
Handel nachbörslich:
7.65
0.14
+1.86%
Schlusskurs vom Vortag:
$8.11
Offen:
$8.16
24-Stunden-Volumen:
1.24M
Relative Volume:
1.11
Marktkapitalisierung:
$307.28M
Einnahmen:
$128.29M
Nettoeinkommen (Verlust:
$-30.69M
KGV:
-9.1585
EPS:
-0.82
Netto-Cashflow:
$-27.17M
1W Leistung:
-14.66%
1M Leistung:
-25.05%
6M Leistung:
-47.08%
1J Leistung:
-84.95%
1-Tages-Spanne:
$7.50
$8.16
1-Wochen-Bereich:
$7.50
$8.96
52-Wochen-Spanne:
$6.32
$55.57
Rxsight Inc Stock (RXST) Company Profile
Firmenname
Rxsight Inc
Sektor
Branche
Telefon
949-521-7822
Adresse
100 COLUMBIA STREET, ALISO VIEJO
Vergleichen Sie RXST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
7.51 | 331.83M | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-10 | Herabstufung | Jefferies | Buy → Hold |
| 2025-07-09 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-07-09 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-07-09 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-05-19 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Eingeleitet | Piper Sandler | Neutral |
| 2025-04-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-04-04 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2025-04-03 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-12-20 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-11 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Eingeleitet | UBS | Buy |
| 2024-10-29 | Eingeleitet | Jefferies | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-08-06 | Bestätigt | Needham | Buy |
| 2024-05-07 | Bestätigt | BTIG Research | Buy |
| 2023-12-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | Eingeleitet | Stifel | Buy |
| 2023-12-04 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-04-13 | Eingeleitet | Oppenheimer | Outperform |
| 2022-12-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | Eingeleitet | Needham | Buy |
Alle ansehen
Rxsight Inc Aktie (RXST) Neueste Nachrichten
RxSight Inc. stock trend outlook and recovery pathStock Surge & Weekly High Return Stock Opportunities - newser.com
When is the best time to exit RxSight Inc.2025 Investor Takeaways & Weekly High Return Stock Opportunities - newser.com
RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Is RxSight Inc. stock bottoming out2025 EndofYear Setup & Free Fast Gain Swing Trade Alerts - newser.com
Candlestick signals on RxSight Inc. stock todayWeekly Investment Recap & Fast Exit and Entry Strategy Plans - newser.com
RxSight's (RXST) Sell (E+) Rating Reaffirmed at Weiss Ratings - MarketBeat
RXSIGHT ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Full technical analysis of RxSight Inc. stock2025 Major Catalysts & Daily Volume Surge Trade Alerts - newser.com
What data driven models say about RxSight Inc.’s futureGap Down & Fast Moving Stock Watchlists - newser.com
Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Investors to Inquire about Securities Investigation - ACCESS Newswire
RxSight Inc. stock trend forecastPortfolio Risk Summary & Real-Time Sentiment Analysis - newser.com
Can RxSight Inc. stock outperform in 2025 bull marketJuly 2025 Trade Ideas & Technical Entry and Exit Alerts - newser.com
How moving averages guide RxSight Inc. tradingPortfolio Update Report & Free Risk Controlled Daily Trade Plans - newser.com
Can volume confirm reversal in RxSight Inc.Stop Loss & Capital Efficient Trade Techniques - newser.com
Trend analysis for RxSight Inc. this week2025 Growth vs Value & Long-Term Growth Plans - newser.com
Is RxSight Inc. stock entering bullish territory2025 Price Targets & Low Risk Growth Stock Ideas - newser.com
Is RxSight Inc a good long term investmentSwing Trading Ideas & Investment Recommendations You Can Trust - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Investors to Reach Out - ACCESS Newswire
What drives RxSight Inc stock priceTop Performing Stocks & Outstanding Investment Returns - earlytimes.in
Head to Head Contrast: Monogram Orthopaedics (NASDAQ:MGRM) versus RxSight (NASDAQ:RXST) - Defense World
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Stockholders to Reach Out - ACCESS Newswire
RxSight Inc Stock Analysis and ForecastTrend Following Strategies & Minimal Investment Portfolio - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Stockholders to Connect - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming DeadlinesRXST - PR Newswire
RxSight, Inc. (NASDAQ:RXST) Receives Average Recommendation of "Reduce" from Brokerages - MarketBeat
RxSight, Inc. (NASDAQ:RXST) Receives Average Recommendation of “Reduce” from Brokerages - Defense World
Shareholders of RxSight, Inc. Should Contact Levi & - GlobeNewswire
RXSIGHT FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
Shareholders of RxSight, Inc. Should Contact Levi & Korsinsky Before September 22, 2025 to - Bluefield Daily Telegraph
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight - Business Wire
DEADLINE ALERT for RXST, RMHIX, FI, and FLYW: The Law - GlobeNewswire
Finanzdaten der Rxsight Inc-Aktie (RXST)
Umsatz
Nettogewinn
Free Cashflow
ENV
Rxsight Inc-Aktie (RXST) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Weinberg Eric | See remarks |
Jun 02 '25 |
Option Exercise |
3.93 |
188,002 |
738,848 |
195,351 |
| Thunen Shelley B | See remarks |
Apr 14 '25 |
Option Exercise |
4.34 |
7,792 |
33,806 |
38,354 |
| Fountain Tamara | Director |
Mar 12 '25 |
Sale |
25.71 |
7,000 |
180,002 |
24,793 |
1.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):